American Gene Technologies International
American Gene Technologies is a clinical-stage biotechnology company based in Rockville, Maryland, focusing on innovative gene therapies aimed at curing serious diseases, including HIV and cancer. The company is recognized for its groundbreaking work in developing patent-protected gene therapies and has achieved significant milestones, such as the successful Phase 1 trial of its AGT103-T HIV gene therapy.
Committed to transforming the future of medicine, American Gene Technologies is actively pursuing clinical cures for complex diseases and has received FDA Orphan Drug Approval for its treatment of phenylketonuria. With a strong emphasis on reducing the time and costs associated with drug development, the company is poised to make remarkable advancements in the healthcare industry.
Generated from the website




